Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abdelli, S.
Right arrow Articles by Bonny, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abdelli, S.
Right arrow Articles by Bonny, C.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:2815-2823, 2004
© 2004 by the American Diabetes Association, Inc.

Intracellular Stress Signaling Pathways Activated During Human Islet Preparation and Following Acute Cytokine Exposure

Saida Abdelli1, Jeff Ansite2, Raphael Roduit1, Tiziana Borsello3, Ippei Matsumoto2, Toshiya Sawada2, Nathalie Allaman-Pillet1, Hugues Henry3, Jacques S. Beckmann1, Bernhard J. Hering2, and Christophe Bonny1

1 Service of Medical Genetics, Lausanne, Switzerland
2 Diabetes Institute for Immunology and Transplantation, University of Minnesota, Minneapolis, Minnesota
3 University Hospital Falaises, Lausanne, Switzerland

Pancreatic islet transplantation may successfully restore normoglycemia in type 1 diabetic patients. However, successful grafting requires transplantation of a sufficient number of islets, usually requiring two or more donors. During the isolation process and following clinical transplantation, islets are subjected to severe adverse conditions that impair survival and ultimately contribute to graft failure. Here, we have mapped the major intracellular stress-signaling pathways that may mediate human islet loss during isolation and following cytokine attack. We found that the isolation procedure potently recruits two pathways consisting of |mitogen-activated protein kinase kinase (MKK)7 -> Jun NH2-terminal kinase (JNK)/p38 -> c-fos| and the |nuclear factor-{kappa}B (NF-{kappa}B) -> iNOS| module. Cytokines activate the |NF-{kappa}B -> iNOS| and |MKK4/MKK3/6 -> JNK/p38| pathways without recruitment of c-fos. Culturing the islets for 48 h after isolation allows for the activated pathways to return to background levels, with expression of MKK7 becoming undetectable. These data indicate that isolation and cytokines recruit different death pathways. Therefore, strategies might be rationally developed to avoid possible synergistic activation of these pathways in mediating islet loss during isolation and following grafting.

Address correspondence and reprint requests to Christophe Bonny, Service of Medical Genetics, 1011 Lausanne-CHUV, Switzerland. E-mail: christophe.bonny{at}chuv.hospvd.ch. Or Bernhard J. Hering, Diabetes Institute for ImmunologyTransplantation, University of Minnesota, 420 Delaware St. SE, Mayo Mailing Code no. 195, Minneapolis, MN 55455. E-mail: bhering{at}tumn.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
D. Mokhtari, J. W. Myers, and N. Welsh
MAPK Kinase Kinase-1 Is Essential for Cytokine-Induced c-Jun NH2-Terminal Kinase and Nuclear Factor-{kappa}B Activation in Human Pancreatic Islet Cells
Diabetes, July 1, 2008; 57(7): 1896 - 1904.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Ferdaoussi, S. Abdelli, J.-Y. Yang, M. Cornu, G. Niederhauser, D. Favre, C. Widmann, R. Regazzi, B. Thorens, G. Waeber, et al.
Exendin-4 Protects {beta}-Cells From Interleukin-1{beta}-Induced Apoptosis by Interfering With the c-Jun NH2-Terminal Kinase Pathway
Diabetes, May 1, 2008; 57(5): 1205 - 1215.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
D. A. Thomas, C. Stauffer, K. Zhao, H. Yang, V. K. Sharma, H. H. Szeto, and M. Suthanthiran
Mitochondrial Targeting with Antioxidant Peptide SS-31 Prevents Mitochondrial Depolarization, Reduces Islet Cell Apoptosis, Increases Islet Cell Yield, and Improves Posttransplantation Function
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 213 - 222.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. S. Hotamisligil
Role of Endoplasmic Reticulum Stress and c-Jun NH2-Terminal Kinase Pathways in Inflammation and Origin of Obesity and Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S73 - S78.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. C. Lewis, L. Shapiro, O. J. Bowers, and C. A. Dinarello
{alpha}1-Antitrypsin monotherapy prolongs islet allograft survival in mice
PNAS, August 23, 2005; 102(34): 12153 - 12158.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.